JP2009537798A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537798A5
JP2009537798A5 JP2009510351A JP2009510351A JP2009537798A5 JP 2009537798 A5 JP2009537798 A5 JP 2009537798A5 JP 2009510351 A JP2009510351 A JP 2009510351A JP 2009510351 A JP2009510351 A JP 2009510351A JP 2009537798 A5 JP2009537798 A5 JP 2009537798A5
Authority
JP
Japan
Prior art keywords
colorectal cancer
complex
marker
hemoglobin
binding agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009510351A
Other languages
English (en)
Japanese (ja)
Other versions
JP4942813B2 (ja
JP2009537798A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/004378 external-priority patent/WO2007134779A1/en
Publication of JP2009537798A publication Critical patent/JP2009537798A/ja
Publication of JP2009537798A5 publication Critical patent/JP2009537798A5/ja
Application granted granted Critical
Publication of JP4942813B2 publication Critical patent/JP4942813B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009510351A 2006-05-19 2007-05-16 結腸直腸癌のマーカーとしてのタンパク質ｓ１００ａ１２の使用 Expired - Fee Related JP4942813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06010439 2006-05-19
EP06010439.5 2006-05-19
PCT/EP2007/004378 WO2007134779A1 (en) 2006-05-19 2007-05-16 Use of protein s100a 12 as a marker for colorectal cancer

Publications (3)

Publication Number Publication Date
JP2009537798A JP2009537798A (ja) 2009-10-29
JP2009537798A5 true JP2009537798A5 (enExample) 2010-02-18
JP4942813B2 JP4942813B2 (ja) 2012-05-30

Family

ID=37087565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009510351A Expired - Fee Related JP4942813B2 (ja) 2006-05-19 2007-05-16 結腸直腸癌のマーカーとしてのタンパク質ｓ１００ａ１２の使用

Country Status (15)

Country Link
US (3) US20090286328A1 (enExample)
EP (1) EP2021794B8 (enExample)
JP (1) JP4942813B2 (enExample)
KR (1) KR101147586B1 (enExample)
CN (1) CN101449163B (enExample)
AT (1) ATE471512T1 (enExample)
AU (1) AU2007251933B2 (enExample)
BR (1) BRPI0711763A2 (enExample)
CA (1) CA2651709A1 (enExample)
DE (1) DE602007007209D1 (enExample)
DK (1) DK2021794T3 (enExample)
ES (1) ES2347485T3 (enExample)
MX (1) MX2008014482A (enExample)
PL (1) PL2021794T3 (enExample)
WO (1) WO2007134779A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957217B2 (en) 2006-08-25 2021-03-23 Ronald A. Weitzman Population-sample regression in the estimation of population proportions
US11151895B2 (en) * 2006-08-25 2021-10-19 Ronald Weitzman Population-sample regression in the estimation of population proportions
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
MX2010008496A (es) * 2008-01-31 2010-08-30 Univ Keio Metodo para la determinacion de sensibilidad a agente anticancerigeno.
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
CN103033623A (zh) * 2012-12-10 2013-04-10 天津市协和医药科技集团有限公司 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法
ES2859645T3 (es) 2013-03-14 2021-10-04 Mayo Found Medical Education & Res Detección de neoplasia
EP3000897B1 (en) * 2013-05-21 2019-10-16 Biomérieux Colorectal cancer prognosis agent kit
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
WO2016160454A1 (en) 2015-03-27 2016-10-06 Exact Sciences Corporation Detecting esophageal disorders
KR20250172724A (ko) 2015-08-31 2025-12-09 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 위 신생물 검출 방법
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
WO2019200177A1 (en) * 2018-04-12 2019-10-17 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
EP4004549A1 (en) * 2019-07-23 2022-06-01 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Progression markers for colorectal adenomas
JP7741067B2 (ja) * 2019-10-18 2025-09-17 エグザクト サイエンシーズ コーポレーション 複数の分析物を用いた糞便抗原検査

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) * 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
DE3838900A1 (de) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung
JPH02193071A (ja) * 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
US7700307B2 (en) * 2003-03-08 2010-04-20 Auvation Limited Mitochondrial stress-70 protein markers for colorectal cancer
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
EP1778869B9 (en) * 2004-07-23 2011-06-15 AspenBio Pharma, Inc. Methods and devices for diagnosis of appendicitis

Similar Documents

Publication Publication Date Title
WO2009029591A3 (en) Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods
WO2009012140A3 (en) Drug selection for lung cancer therapy using antibody-based arrays
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
WO2008021290A8 (en) Organ-specific proteins and methods of their use
WO2011046964A3 (en) Inhibitors of bruton's tyrosine kinase
WO2005047860A3 (en) Antibodies to alpha-synuclein
WO2008073899A3 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
WO2009113814A3 (ko) 간암 진단용 단백질성 마커
WO2009019368A3 (fr) Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal
JP2009539082A5 (enExample)
WO2008136848A3 (en) Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
EP2212700B8 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2009019365A3 (fr) Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal
JP2010526995A5 (enExample)
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2006036175A3 (en) Wnt proteins and detection and treatment of cancer
WO2006036179A3 (en) Frizzled proteins and detection and treatment of cancer
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
WO2008108873A3 (en) Molecular biosensors for detecting macromolecules and other analytes
WO2009019369A3 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal
WO2009132655A3 (en) Design and use of sortilin specific molecular imaging ligands
DE502004009217D1 (de) Differenzialdiagnostik mit Hepcidin
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom